Pharmaceutical Assets Portal project
Scientists know there are drugs that have been developed, tested and found lacking for one disease that might help patients with a completely different condition. But the trick for researchers has always been finding out about them.
While the National Institutes of Health and the pharmaceutical industry maintain portfolios of investigational and FDA-approved compounds, information and access to drugs that are no longer in active development remain difficult to obtain
The institutional team is collaborating with a number of industry partners, including the Virginia-based technology company, Biovista, which provided initial data for the portal. …